10 Mar 2026 | 07:00
Director/PDMR Shareholding
/**/
RNS Number : 9386V Frontier Developments PLC 10 March 2026
10 March 2026
FRONTIER DEVELOPMENTS PLC
PDMR Dealing
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
David Braben
2
Reason for the notification
a)
Position/status
President and Founder
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Frontier Developments plc
b)
LEI
213800B9LGPWUAZ9GX18
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.5p each
ISIN: GB00BBT32N39
b)
Nature of the transaction
Sale of Ordinary Shares in line with the details set out in the launch of the Share Buyback Programme on 26 February 2026
c)
Price(s) and volume(s)
Price(s)
Volume(s)
379.25
7,500
d)
Aggregated information
- Aggregated volume
- Price
N/A - single transaction
e)
Date of the transaction
09 March 2026
f)
Place of the transaction
London Stock Exchange, AIM
Enquiries:
Frontier Developments
IR@frontier.co.uk
+44 (0)1223 394300
Peel Hunt - Nomad and Joint Corporate Broker +44 (0)20 7418 8900
Neil Patel / Ben Cryer / Kate Bannatyne
About Frontier Developments plc
Frontier is a leading independent developer and publisher of video games founded in 1994 by David Braben, co-author of the iconic Elite game. Based in Cambridge, Frontier uses its proprietary COBRA game development technology to create innovative genre-leading games, primarily for personal computers and video game consoles.
Frontier's LEI number: 213800B9LGPWUAZ9GX18.
www.frontier.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHBRGDXXSGDGLC